Mercury Bio Executives to Present Novel, Disruptive Drug Delivery Platform at 2024 Biotech Showcase

Posted on by

Investor Meetings Now Being Scheduled during J.P. Morgan 42nd Annual Healthcare Conference SANTA FE, N.M., Dec. 20, 2023 /PRNewswire/ — Mercury Bio, (www.mercurybio.com) a Santa Fe, NM–based biotech company commercializing an innovative and highly disruptive drug delivery platform, today…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.